Your browser doesn't support javascript.
loading
Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
Özen, Tunc; Kahraman, Filiz Cebeci; Öcal, Sevliya; Ovalı, Hüsnü Fahri.
  • Özen, Tunc; Istanbul Medeniyet University. Göztepe Prof. Dr. Süleyman Yalçın City Hospital. Department of Dermatology. Istanbul. TR
  • Kahraman, Filiz Cebeci; Istanbul Medeniyet University. Göztepe Prof. Dr. Süleyman Yalçın City Hospital. Department of Dermatology. Istanbul. TR
  • Öcal, Sevliya; Istanbul Medeniyet University. Göztepe Prof. Dr. Süleyman Yalçın City Hospital. Department of Pediatric Infectious Diseases. Istanbul. TR
  • Ovalı, Hüsnü Fahri; Istanbul Medeniyet University. Göztepe Prof. Dr. Süleyman Yalçın City Hospital. Department of Pediatric Diseases. Istanbul. TR
An. bras. dermatol ; 98(2): 208-215, March.-Apr. 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1429653
ABSTRACT
Abstract

Background:

Cutaneous manifestations of Coronavirus Disease-2019 (COVID-19) disease have not yet been fully described in hospitalized pediatric patients.

Objectives:

This prospective study aims to demonstrate the skin, mucosal, and nail findings of hospitalized children with COVID-19.

Methods:

The authors included hospitalized pediatric patients. Two dermatologists examined skin, hair, nails, and mucosa. Patients with drug eruptions were excluded with an anamnesis, clinical and laboratory test results.

Results:

Out of 46 enlisted patients, 19 (41,3%) patients displayed skin, mucosal or nail findings. Skin findings were seen on 14 (30.4%) patients. Ten (22%) patients presented skin findings matching described patterns. Half of the patients with patterned rashes had confluent erythematous/maculopapular/morbilliform rashes. Eleven out of 46 (23.9%) patients developed periorbital erythema and edema. Ten (22%) patients had at least one oral mucosal finding. One telogen effluvium, one blue nail, and one flag sign on nails were noticed. Nine (19.5%) patients out of 46 had developed MIS-C. MIS-C patients had mucocutaneous manifestations except one (88.8%). Study

limitations:

The authors have detected a higher rate of mucocutaneous manifestations compared to out-patients with mild COVID-19 because the study is based on hospitalized patients only.

Conclusions:

Pediatric COVID-19 patients are more susceptible to developing mucocutaneous manifestations compared to adults. The authors propose COVID-19 should be acknowledged as one of the viral exanthem rashes of childhood. The authors noticed that the most common findings were periorbital erythema and edema. The confluent erythematous/maculopapular/morbilliform rashes appear to be the most common patterns associated with severe COVID-19.


Full text: Available Index: LILACS (Americas) Type of study: Diagnostic study / Observational study / Risk factors Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2023 Type: Article Affiliation country: Turkey Institution/Affiliation country: Istanbul Medeniyet University/TR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Type of study: Diagnostic study / Observational study / Risk factors Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2023 Type: Article Affiliation country: Turkey Institution/Affiliation country: Istanbul Medeniyet University/TR